Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Re Directorate

22nd Oct 2014 12:12

RNS Number : 0001V
GlaxoSmithKline PLC
22 October 2014
 



 

 

 

 

Change to Director's Details - Dr Moncef Slaoui

 

GlaxoSmithKline plc (the "Company") today confirms that Dr Moncef Slaoui, an Executive Director, is appointed Chairman, Vaccines, with immediate effect.

 

This appointment will ensure more focused management of the Company's Vaccines business in advance of the completion of the proposed 3 part transaction with Novartis announced earlier this year. Dr Slaoui will continue to provide scientific and technical counsel on pharmaceutical R&D activities to the CEO and Board.

 

Dr Slaoui was previously Chairman, Global R&D and Vaccines.

 

 

V A Whyte

Company Secretary

 

22 October 2014

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFEWFFEFLSESS

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,632.33
Change89.77